Login
$CRVL
$81.58 -$1.09 (1.32%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q1 FY2027
As of Jun 30, 2026
Q4 FY2026
As of Mar 31, 2026
Q3 FY2026
As of Dec 31, 2025
Q2 FY2026
As of Sep 30, 2025
Q1 FY2026
As of Jun 30, 2025
Q4 FY2025
As of Mar 31, 2025
Q3 FY2025
As of Dec 31, 2024
Q2 FY2025
As of Sep 30, 2024
Q1 FY2025
As of Jun 30, 2024
Q4 FY2024
As of Mar 31, 2024
Q3 FY2024
As of Dec 31, 2023
Q2 FY2024
As of Sep 30, 2023
Q1 FY2024
As of Jun 30, 2023
Q4 FY2023
As of Mar 31, 2023
Q3 FY2023
As of Dec 31, 2022
Q2 FY2023
As of Sep 30, 2022
Q1 FY2023
As of Jun 30, 2022
Q4 FY2022
As of Mar 31, 2022
Q3 FY2022
As of Dec 31, 2021
Q2 FY2022
As of Sep 30, 2021
Assets
Current Assets
Cash and cash equivalents
Customer deposits
Accounts receivable, net
Prepaid taxes and expenses
Total current assets
Property and equipment, net
Goodwill
Other intangibles, net
Right-of-use asset, net
Deferred tax asset, net
Other assets
TOTAL ASSETS
Liabilities and Stockholders' Equity
Current Liabilities
Accounts and taxes payable
Accrued liabilities
Total current liabilities
Long-term lease liabilities
Total liabilities
Stockholders' Equity
Common stock, $0.0001 par value: 360,000,000 shares authorized at June 30, 2026 and March 31, 2026; 166,232,817 shares issued (50,596,284 shares outstanding, net of Treasury shares) and 166,168,732 shares issued (50,909,297 shares outstanding, net of Treasury shares) at June 30, 2026 and March 31, 2026, respectively
Paid-in capital
Treasury stock (115,636,533 shares at June 30, 2026 and 115,259,435 shares at March 31, 2026)
Retained earnings
Total stockholders' equity
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support